Summary
- Current Price
- As of today, NAMS price is $35.76, up +1.48% on
- Current Price All-Time High
- NAMS price is currently -14.86% below its historical high of $42.00 set on
- Market Cap
- NAMS current market cap is $4B, up +93.11% over the past 365 days
- PE Ratio
- NAMS PE ratio is unknown
- Revenue
- NAMS current annual revenue is $45.56M, up +223.37% year-over-year
- Next Earnings
- As of today, the next earnings release for NAMS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | NewAmsterdam Pharma Company N.V. |
| Ticker | NASDAQ: NAMS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | newamsterdampharma.com |
| Employees | 77 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $35.76 | |
| Price, 1D Change | +1.48% | |
| $4B | ||
| - | ||
| - | ||
| 0.89 | ||
| $46M | ||
| Revenue, 1Y Change | +223.37% | |
| -$2.56 | ||
| EPS, 1Y Change | -18.89% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.56 | ||
| EPS Estimate | N/A | -$1.33 |
| EPS Est. Change | N/A | +48.11% |
| $45.56M | ||
| Revenue Estimate | N/A | $23.27M |
| Revenue Est. Change | N/A | -48.93% |
| Current Price | $35.76 | |
| Price Target | - | $47.70 |
| Price Tgt. Change | - | +33.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.24 | -$2.15 | +3.86% | |
| -$1.98 | -$2.56 | -29.02% | |
| -$1.33 | N/A | +48.11% | |
| -$1.51 | N/A | +41.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.24M | $14.09M | -1.05% | |
| $31.13M | $45.56M | +46.35% | |
| $23.27M | N/A | -48.93% | |
| $37.72M | N/A | -17.22% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $35.76 | |
| $28.46 | ||
| SMA 200 vs Price | -20.42% | |
| $34.12 | ||
| SMA 50 vs Price | -4.59% | |
| 0.89 | ||
| $1.65 | ||
| 59.85 | ||
| 43.07% | ||
| 57.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $45.56M | ||
| -$2.56 | ||
| $45.45M | ||
| 99.75% | ||
| -$176.29M | ||
| -386.91% | ||
| -$241.60M | ||
| -530.25% | ||
| -$241.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 8.08 | ||
| 8.08 | ||
| - | ||
| 3 | ||
| 21.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 115.05 | ||
| 5.57 | ||
| -16.53 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $757.50M | ||
| $771.74M | ||
| $864.62M | ||
| $863.41M | ||
| $107.12M | ||
| $106.92M | ||
| $448.00K | ||
| $246.00K | ||
| $4.74M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $221.85M | ||
| $221.85M | ||
| $113.00K | ||
| $70.45M | ||
| $113.00K | ||
| $0.00 | ||
| -$1,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$158.56M | ||
| -$62.85M | ||
| $659.51M | ||
| $672.00K | ||
| -$159.24M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| Stifel | → | |
| Goldman Sachs | → | |
| RBC Capital | → | |
| Needham | → | |
| Citigroup | → | |
| Wells Fargo | ||
| RBC Capital | → | |
| Goldman Sachs | ||
| Citigroup |
Analyst sentiment
Institutional ownership
Screeners with NAMS
FAQ
What is the ticker symbol for NewAmsterdam Pharma Company N.V.?
The ticker symbol for NewAmsterdam Pharma Company N.V. is NASDAQ:NAMS
Does NewAmsterdam Pharma Company N.V. pay dividends?
No, NewAmsterdam Pharma Company N.V. does not pay dividends
What sector is NewAmsterdam Pharma Company N.V. in?
NewAmsterdam Pharma Company N.V. is in the Healthcare sector
What industry is NewAmsterdam Pharma Company N.V. in?
NewAmsterdam Pharma Company N.V. is in the Biotechnology industry
What country is NewAmsterdam Pharma Company N.V. based in?
NewAmsterdam Pharma Company N.V. is headquartered in Netherlands
When did NewAmsterdam Pharma Company N.V. go public?
NewAmsterdam Pharma Company N.V. initial public offering (IPO) was on February 9, 2021
Is NewAmsterdam Pharma Company N.V. in the S&P 500?
No, NewAmsterdam Pharma Company N.V. is not included in the S&P 500 index
Is NewAmsterdam Pharma Company N.V. in the NASDAQ 100?
No, NewAmsterdam Pharma Company N.V. is not included in the NASDAQ 100 index
Is NewAmsterdam Pharma Company N.V. in the Dow Jones?
No, NewAmsterdam Pharma Company N.V. is not included in the Dow Jones index
When was NewAmsterdam Pharma Company N.V. last earnings report?
NewAmsterdam Pharma Company N.V.'s most recent earnings report was on February 18, 2026
When does NewAmsterdam Pharma Company N.V. report earnings?
The date for NewAmsterdam Pharma Company N.V.'s next earnings report has not been announced yet
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams